
Leyden Labs Shows Feasibility of a Novel Antibody-Based Nasal Spray for Influenza Prevention
Leyden Labs Demonstrates Feasibility of Novel Antibody-Based Nasal Spray for Flu Prevention Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced landmark preclinical and clinical data in Science Translational Medicine supporting the…












